Home Cart Sign in  
Chemical Structure| 342639-96-7 Chemical Structure| 342639-96-7

Structure of KRIBB11
CAS No.: 342639-96-7

Chemical Structure| 342639-96-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

KRIBB11 functions as an inhibitor of Heat shock factor 1 (HSF1), with an IC50 of 1.2 μM.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of KRIBB11

CAS No. :342639-96-7
Formula : C13H12N6O2
M.W : 284.27
SMILES Code : O=[N+](C1=CC=C(NC)N=C1NC2=CC3=C(NN=C3)C=C2)[O-]
MDL No. :MFCD30182306
InChI Key :NDJJEQIMIJJCLL-UHFFFAOYSA-N
Pubchem ID :69894253

Safety of KRIBB11

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of KRIBB11

DNA

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Endothelial cells 10 µM 24 h to assess the effects of HSF1 on endothelial cells and found that fewer blood vessels and lower VEGF and CD31 expression were observed in the presence of HSF1 inhibitors. PMC9525722
BT-549rDOX20/sh Ctrl 20 μM 48 h To assess the effect of KRIBB11 on cell death, demonstrating increased total cell death compared to DOX treatment alone. PMC5852393

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice popliteal LN metastasis models Intraperitoneal injection 70 mg/kg every 2 days KRIBB11 reduced lymphatic metastatic rate and expression of Ki67. PMC9118058

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.52mL

0.70mL

0.35mL

17.59mL

3.52mL

1.76mL

35.18mL

7.04mL

3.52mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
 

Historical Records

Categories